Valuation: Healius Limited

Market Cap 428M 285M 259M 239M 217M 408M 26.36B 2.91B 1.16B 14.4B 1.07B 1.05B 45.18B P/E 2027 *
109x
P/E 2028 * -125x
Enterprise Value 1.21B 801M 729M 672M 611M 1.15B 74.15B 8.18B 3.25B 40.5B 3B 2.94B 127B EV / Sales 2027 *
0.87x
EV / Sales 2028 * 0.85x
Free-Float
75%
Yield 2027 *
-
Yield 2028 * 1.33%
1 day-2.48%
1 week+2.61%
Current month+19.19%
1 month+51.28%
3 months+26.88%
6 months+71.01%
Current year-34.81%
1 week 0.57
Extreme 0.57
0.62
1 month 0.39
Extreme 0.39
0.62
Current year 0.3
Extreme 0.3
1.05
1 year 0.3
Extreme 0.3
1.07
3 years 0.3
Extreme 0.3
1.86
5 years 0.3
Extreme 0.3
5.54
10 years 0.3
Extreme 0.3
5.54
Manager TitleAgeSince
Chief Executive Officer - 05/03/2024
Director of Finance/CFO - 13/10/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 21/08/2018
Chairman 65 28/11/2023
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
10/27/26 A Buy

Chief Executive Officer

117,433 0.0162%
10/26/26 A Buy

Director

35,000 0.0048%
10/23/26 A Buy

Chief Executive Officer

232,941 0.0321%
Change 5-day change 1-year change 3-year change Capi.($)
-2.48%+2.61%-37.23%-67.85% 285M
+1.00%-9.52%+6.31%+18.43% 103B
+3.31%-4.70%-0.15%+91.45% 99.34B
-5.70%-14.32%+21.21%+399.00% 39.62B
-0.73%-0.48%+14.07%+94.82% 31.77B
-0.47%-0.90%+40.41%+73.91% 29.81B
-0.31%-0.51%+37.67%+91.53% 28.42B
-0.15%-7.99%+40.98%+305.22% 20.95B
-0.62%-2.67%-15.69%-20.65% 19.39B
0.00%-0.38%-2.83%+32.77% 16.97B
Average -0.62%-3.83%+10.48%+101.86% 39B
Weighted average by Cap. +0.37%-5.85%+12.04%+105.51%

Financials

2027 *2028 *
Net sales 1.39B 921M 839M 773M 703M 1.32B 85.32B 9.41B 3.74B 46.6B 3.46B 3.38B 146B 1.41B 940M 856M 789M 718M 1.35B 87.03B 9.6B 3.82B 47.54B 3.53B 3.45B 149B
Net income -2.77M -1.84M -1.67M -1.54M -1.4M -2.63M -170M -18.77M -7.46M -92.93M -6.89M -6.75M -292M -4.35M -2.89M -2.63M -2.42M -2.2M -4.13M -267M -29.49M -11.72M -146M -10.83M -10.6M -458M
Net Debt 777M 516M 470M 433M 394M 739M 47.79B 5.27B 2.1B 26.1B 1.94B 1.9B 81.92B 776M 516M 470M 433M 394M 739M 47.77B 5.27B 2.09B 26.09B 1.94B 1.89B 81.88B
Projected Income Statement - Annual - Healius Limited
Logo Healius Limited
Healius Limited is a healthcare company. The Company's specialized pathology businesses deliver healthcare services across Australia. It provides pathology services, including specialty pathology and clinical trials. It offers medical laboratory and pathology services through a variety of specialty brands. It provides medical laboratory and pathology services across key diagnostic activities. These include anatomical pathology (histopathology and cytology), clinical pathology (biochemistry, hematology, immunology and microbiology), genomic diagnostics and veterinary pathology. Its brands include Abbot, Agilex Biolabs, Dorevitch, Gastrolab, Genomic Diagnostics, IQ Pathology, Kossard Dermatopathology, Laverty Pathology, QML Pathology, TML Pathology, Vetnostics Pathology and Western Diagnostic Pathology (WDP). These brands operate in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia and Northern Territory, Tasmania, and South Australia.
Employees
5,419
Date Price Change Volume
20/11/26 A$0.5900 -2.48% 2,036,181
19/11/26 A$0.6050 +4.31% 6,477,376
18/11/26 A$0.5800 -3.33% 1,088,688
17/11/26 A$0.6000 +3.45% 6,740,450
16/11/26 A$0.5800 +0.87% 9,657,591
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Healius Limited
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
0.5900AUD
Average target price
0.5498AUD
Spread / Average Target
-6.81%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Healius Limited